InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Petree Daniel H, 董事. Officer active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 2 filings have been published. Activity tracked since 8 February 2022. The latest transaction was filed on 27 June 2023 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Petree Daniel H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
18,409 股0Common StockSEC:0001209191-23-040213:0
4,545 股@ US$4.36100.0% 占其流量Common StockSEC:0001209191-22-008198:0
2 条申报中的 2 条
About Petree Daniel H
Daniel H. Petree is a Director at SUTRO BIOPHARMA, INC., a biotechnology company. As a director, he contributes to the governance of the company and to strategic decision-making. His experience in the biotechnology field is an asset for SUTRO.
